The Knowledge Shelf

Development of Cancer Drugs for Use in Novel Combination – Determining the Contribution of the Individual Drugs’ Effects

KRASNIY OKTYABR INC. USA. of BROOKLYN, NY, is recalling its “ARAL SILVER VOBLA” brand “ARAL”, because the product was found to be uneviscerated.

Sandoz, Inc. (“Sandoz”) is initiating a voluntary nationwide recall expansion of one additional lot of Cefazolin for Injection, USP, 1 gram per vial. The lot is being recalled due to a customer complaint indicating that four (4) vials incorrectly labelled as Penicillin G Potassium for Injection, USP

The FDA is alerting health care providers to the recall of certain VasoView HemoPro devices due to risk of silicone detachment during use, and supply concerns.

This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program.

Kratom is not lawfully marketed in the U.S. as a drug product, a dietary supplement, or a food additive in conventional food.

Clinical Investigator

CGMP/Finished Pharmaceuticals/Adulterated

Unapproved New Drugs/Misbranded

Unapproved New Drugs/Misbranded